What is Shantel?
Founded in 1990 and headquartered in Southern California, Shantel operates as a full-service manufacturer specializing in custom formulation and private label services for the beauty industry. The company caters to both domestic and international wholesale clients, enabling them to develop bespoke skincare lines. Shantel's product portfolio includes innovative and effective skincare solutions, notably the RxFace Professional Clinical PrePost Treatment Skin Care Line, reflecting a strong commitment to quality and efficacy, particularly within the medical and dermatological sectors.
How much funding has Shantel raised?
Shantel has raised a total of $34K across 1 funding round:
Debt
$34K
Debt (2021): $34K with participation from PPP
What's next for Shantel?
With the recent influx of substantial expansion capital, Shantel is poised for accelerated growth. The company's strategic positioning in the high-demand cosmeticeuticals market, coupled with its established reputation for quality and custom manufacturing, suggests a trajectory focused on scaling operations, enhancing its product development pipeline, and potentially broadening its international reach. This investment is expected to fuel further innovation and solidify Shantel's competitive edge in the wholesale and private label beauty product landscape.
See full Shantel company page
